Skip to content
Clinical Trials – home

Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice

Research site

Croatia Ulica Ljudevita Gaja 2, 49217 Krapinske Toplice, Croatia

  • 7 trials recruiting
  • Arteriosclerosis · Type 2 diabetes mellitus · Obesity
  • Adult patients

About Specializations

Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice in Krapinske Toplice, Croatia specialises in clinical trials of conditions such as Arteriosclerosis, Type 2 diabetes mellitus, Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice, most trials focus on cardiovascular disease, especially conditions such as acute coronary syndrome, atrial fibrillation, heart failure, and atherosclerotic cardiovascular disease. The research is aimed at testing new treatments and improving prevention of serious events like heart attack, stroke, and cardiovascular death.

  • Preventing major cardiovascular events in people at high risk
  • Improving protection against stroke and embolism in atrial fibrillation
  • Evaluating therapies for heart failure, cardiomyopathy, and post-infarction care
  • Studying approaches to lower cardiovascular risk in patients with established vascular disease

This work reflects a strong clinical interest in both long-term risk reduction and urgent care for patients with complex heart and blood vessel conditions.

Nutritional and Metabolic Diseases

The site also conducts trials in nutritional and metabolic disease, with research centered on type 2 diabetes, overweight, obesity, and lipid disorders such as severe hypertriglyceridemia. These studies are designed to assess new therapies that may improve blood sugar control, support weight loss, and reduce metabolic and cardiovascular complications.

  • Testing treatments for better glucose control in type 2 diabetes
  • Evaluating therapies for weight reduction in overweight and obesity
  • Studying options for severe hypertriglyceridemia and related risk
  • Exploring treatments that link metabolic health with cardiovascular prevention

The research profile at this hospital shows a clear connection between metabolic care and heart health, with many studies aiming to improve outcomes for patients who have more than one chronic condition.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulica Ljudevita Gaja 249217 Krapinske TopliceCroatia
Recruiting now
7 trials
Conditions studied
13

More sites in Krapinske TopliceCroatia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

18 clinical trials

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:CroatiaCroatia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Hypertriglyceridaemia

Not recruiting

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.